InterCure Stock

InterCure Net Margin

The Net Profit Margin of InterCure (INCR.TA) as of Jun 26, 2026 is -0.28.In the previous year, Net Profit Margin was -0.17 — a change of 62.89% (lower).

Net Margin

-0.28

YoY

62.89%

Last updated:

Net Profit Margin of InterCure is 2026 -0.28 . Net Profit Margin of InterCure was 2025 -0.17 . It decreases by 62.89% lower compared to the previous year.

For InterCure, the net margin of -28.4% is up versus -57.2% a few years ago.

Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

Net Profit Margin of InterCure amounted to -0.17 -0.28

Access this data via the Eulerpool API

Margins — InterCure

All Key Metrics — InterCure